AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31744313
Drug: Local Corticosteroid
RxNorm normalized name: Corticosteroids acting locally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local Corticosteroid Injection (LCI)
Trial: 23356886
Drug: 14-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 14-day regimen with high-dose PPI (lansoprazole 60 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 1 g once daily)
Trial: 23356886
Drug: 7-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 7-day regimen with high-dose PPI (lansoprazole 60 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 1 g once daily)
Trial: 20966907
Drug: Parent-only (PO)
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-only (PO) treatment
Trial: 20966907
Drug: Parent +
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent + child (PC) treatment
Trial: 8156447
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy with Dermatophagoides pteronyssinus at high doses
Trial: 3264709
Drug: Propofol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.5 mg kg‐1 for induction and maintenance with 70% nitrous oxide in oxygen
Trial: 3264709
Drug: Thiamylal 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiamylal 4.0 mg kg‐1 for induction and maintenance with 70% nitrous oxide in oxygen
Trial: 31321928
Drug: Morning dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dose first (AB sequence)
Trial: 31321928
Drug: Evening dose
RxNorm normalized name: Jornay PM, (evening dose) 60 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dose first (BA sequence)
Trial: 27476354
Drug: Ibuprofen (Control)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (Control)
Trial: 20721883
Drug: Taribavirin (TBV)
RxNorm normalized name: Ribavirin
DrugBank: Taribavirin (DB06408)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taribavirin (TBV) 20 mg/kg/day
Trial: 20721883
Drug: Taribavirin (TBV)
RxNorm normalized name: Ribavirin
DrugBank: Taribavirin (DB06408)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taribavirin (TBV) 25 mg/kg/day
Trial: 20721883
Drug: Taribavirin (TBV)
RxNorm normalized name: Ribavirin
DrugBank: Taribavirin (DB06408)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taribavirin (TBV) 30 mg/kg/day
Trial: 20721883
Drug: Ribavirin (RBV)
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ribavirin (RBV) 800-1400 mg/day
Trial: 10540659
Drug: Pulsed spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed spray
Trial: 9005788
Drug: Ofloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 400 mg once a day for 7 to 14 days (average 11 days), administered intravenously for the first 3-5 days and then orally
Trial: 8695563
Drug: Prophylactic surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic surfactant treatment
Trial: 8695563
Drug: Rescue surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue surfactant treatment
Trial: 2007937
Drug: Surfactant treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant treatment (both prophylactic and rescue)
Trial: 369009
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution irrigation (Control)
Trial: 30786157
Drug: Melatonin 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.075 mg/kg (maximum 5 mg)
Trial: 30786157
Drug: Melatonin 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.15 mg/kg (maximum 10 mg)
Trial: 30786157
Drug: Melatonin 0.3
RxNorm normalized name: melatonin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.3 mg/kg (maximum 20 mg)
Trial: 30786157
Drug: Melatonin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (all dose levels)
Trial: 18757193
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy
Trial: 28575414
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (L-AMB) at 5 mg/kg intravenously, twice weekly
Trial: 23636036
Drug: Perennial immunotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perennial immunotherapy (PIT)
Trial: 23636036
Drug: Preseasonal immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preseasonal immunotherapy (PSIT)
Trial: 15082209
Drug: 2-stage implant
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-stage implant
Trial: 15082209
Drug: 1-stage implant
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-stage implant
Trial: 9924848
Drug: Furosemide/morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide/morphine
Trial: 7999403
Drug: Anti-emetic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-emetic treatment (specifics not provided)
Trial: 3186615
Drug: Verapamil 240
RxNorm normalized name: verapamil 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 240 mg sustained release tablets once daily
Trial: 3186615
Drug: Verapamil 120
RxNorm normalized name: verapamil 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 120 mg conventional tablets administered twice daily
Trial: 29562260
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist trigger followed by specialized regimen (1500 IU hCG) at time of oocyte retrieval plus oral estradiol and intramuscular progesterone during luteal phase
Trial: 29562260
Drug: hCG trigger
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hCG trigger (5000 IU) with luteal support (oral estradiol and vaginal progesterone)
Trial: 28252533
Drug: Oxaliplatin-based chemotherapy
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin-based chemotherapy (arm A)
Trial: 28252533
Drug: Oxaliplatin-based chemotherapy
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin-based chemotherapy plus cetuximab (arm B)
Trial: 21467190
Drug: Tramadol (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (50, 100, 200, and 400 mg)
Trial: 21467190
Drug: Hydromorphone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone (4 and 8 mg)
Trial: 21467190
Drug: Methylphenidate (30
RxNorm normalized name: methylphenidate (30/70 release) 10 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (30 and 60 mg)
Trial: 15153211
Drug: Clonidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (2 microg.kg(‐1)) added to bupivacaine (1 mg.kg(‐1) 0.125%)
Trial: 15153211
Drug: Saline added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline added to bupivacaine (1 mg.kg(‐1) 0.125%)
Trial: 11444468
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of colloidal bismuth subcitrate and metronidazole or omeprazole, clarithromycin and amoxycillin for H. pylori eradication
Trial: 11444468
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulphate for anaemia treatment
Trial: 9765010
Drug: Fluconazole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (50 mg/day for 7 days)
Trial: 9765010
Drug: Nystatin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nystatin (1 mL 4 times a day for 21 days)
Trial: 7824094
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) treatment as mono-therapy (n = 36) or polytherapy (n = 16) with a mean dosage of 17 mg/kg body weight.
Trial: 7824094
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) treatment in polytherapy (n = 16).
Trial: 7824094
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) treatment as a nonretarded formulation.
Trial: 7824094
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) treatment.
Trial: 3385554
Drug: Glycine-fortified ORS
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycine-fortified ORS (55 or 110 mmol/L glycine)
Trial: 31343447
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available comparator gels
Trial: 15874923
Drug: Metoprolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (50 mg twice daily, supplemented by intravenous doses when necessary)
Trial: 28621820
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy (ICBT)
Trial: 28468739
Drug: Lenalidomide maintenance
RxNorm normalized name: Lenalidomide
DrugBank: Lenalidomide (DB00480)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lenalidomide maintenance (25 mg po for 21 days)
Trial: 26125454
Drug: Local incision
RxNorm normalized name: INCISED NOTOPTERYGIUM RHIZOME OR ROOT (NOTOPTERYGIUM FRANCHETII)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local incision warming (6 post-operative treatments)
Trial: 18385963
Drug: Empiric studies
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Empiric studies concerning the treatment of depressive disorders in children and adolescents; specific interventions not detailed.
Trial: 8922764
Drug: Droperidol 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.04 mg.mg-1 of PCA morphine
Trial: 8922764
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (including droperidol 0.0 and 0.02 mg.mg-1 of PCA morphine)
Trial: 3901661
Drug: Cholestyramine 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine 2 g twice daily
Trial: 3901661
Drug: Loperamide 0.10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide 0.10 mg/kg divided in three doses
Trial: 3901661
Drug: Placebo 2
RxNorm normalized name: Ethinyl Estradiol/Norethindrone Acetate;Placebo 20 MCG-1 MG; NA Oral Tablet, Disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 2 g twice daily
Trial: 30142767
Drug: Socheongryong-tang (SCRT)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Socheongryong-tang (SCRT) taken twice daily for 2 weeks
Trial: 30142767
Drug: Cetirizine taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine taken once daily for 2 weeks
Trial: 14558052
Drug: Intensive dynamic
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive dynamic exercise program (75 minutes, twice a week, for 2 years)
Trial: 6749152
Drug: vitamin K2
RxNorm normalized name: Vitamin K2
DrugBank: Menaquinone 6 (DB14936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vitamin K2 6 mg
Trial: 6749152
Drug: vitamin K2
RxNorm normalized name: Vitamin K2
DrugBank: Menaquinone 6 (DB14936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vitamin K2 2 mg
Trial: 6749152
Drug: vitamin K1
RxNorm normalized name: vitamin K1
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vitamin K1 2 mg
Trial: 24727030
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (saline solution instillation)
Trial: 21815168
Drug: Dietary treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatments with fish oil and vegetable oils
Trial: 10749457
Drug: Heptavalent CRM197
RxNorm normalized name: Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heptavalent CRM197 pneumococcal conjugate vaccine
Trial: 1302788
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose midazolam
Trial: 2938871
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of alpha‐human atrial natriuretic peptide (alpha‐h‐ANP) at a dose of 15 pmol min‐1 kg‐1
Trial: 2938871
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of alpha‐h‐ANP at a dose of 1.5 pmol min‐1 kg‐1
Trial: 2938871
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of alpha‐h‐ANP
Trial: 18031444
Drug: Early loading
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early loading (6 weeks after implant placement)
Trial: 18031444
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading (6 months after implant placement)
Trial: 7733024
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg zinc supplement (ZS, n = 40)
Trial: 30941440
Drug: Painful shocks
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Painful shocks administered after presentation of some words (pain condition)
Trial: 30941440
Drug: No shocks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No shocks administered (pain-free condition)
Trial: 22088414
Drug: Branded etanercept
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Branded etanercept (25 mg)
Trial: 22088414
Drug: Biosimilar etanercept
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Biosimilar etanercept (25 mg)
Trial: 17300242
Drug: ALA-PDT (20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-PDT (20% ALA solution under occlusive dressing for 3 h followed by helium-neon laser irradiation at 100 J cm(‐2) and 100 mW power)
Trial: 17300242
Drug: ALA-PDT (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-PDT (after two treatments)
Trial: 17300242
Drug: Control (CO2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (CO2 laser treatment)
Trial: 9463202
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of ketorolac
Trial: 3555276
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of diclofenac
Trial: 9059768
Drug: Insulin-dependent diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-dependent diabetes mellitus (IDDM)
Trial: 9059768
Drug: Non-insulin-dependent diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-insulin-dependent diabetes mellitus (NIDDM)
Trial: 2900816
Drug: 200 mcg
RxNorm normalized name: CrM 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg of broxaterol hydrochloride
Trial: 2900816
Drug: 400 mcg
RxNorm normalized name: Biotin 400 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mcg of broxaterol hydrochloride
Trial: 2900816
Drug: 200 mcg
RxNorm normalized name: CrM 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg of salbutamol
Trial: 28431145
Drug: Oral glucosamine
RxNorm normalized name: glucosamine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucosamine sulphate
Trial: 24461666
Drug: Ivacaftor 150
RxNorm normalized name: ivacaftor 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivacaftor 150 mg twice daily
Trial: 20684151
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel microsphere (TGM) 0.04% pump
Trial: 20684151
Drug: Adapalene 0.1%
RxNorm normalized name: ADAPALENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapalene 0.1% plus benzoyl peroxide 2.5% gel (ADA-BPO 0.1%/2.5%)
Trial: 18064474
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg x 2 daily during radiation
Trial: 18064474
Drug: Uracil-tegafur 300
RxNorm normalized name: tegafur / uracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uracil-tegafur 300 mg/m2 daily during radiation
Trial: 1611979
Drug: Ornipressin (POR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornipressin (POR 8) at a standard concentration of 0.2 i.u./ml
Trial: 1611979
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl solution (Control)
Trial: 26975694
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment (without psychoeducation)
Trial: 18922613
Drug: Tooth Mousse
RxNorm normalized name: Sus scrofa tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tooth Mousse (TM) applied for 60 min daily for 7 days; smear layer retained (group 1)
Trial: 18922613
Drug: Tooth Mousse
RxNorm normalized name: Sus scrofa tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tooth Mousse (TM) applied for 60 min daily for 7 days; smear layer removed (group 2)
Trial: 18922613
Drug: Preconditioning with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preconditioning with 20% polyacrylic acid (CC)
Trial: 24654454
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) treatment
Trial: 8669405
Drug: Ethanol (5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (5% of total daily energy intake)
Trial: 8669405
Drug: Carbohydrate (5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (5% of total daily energy intake)
Trial: 9151364
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg THIP
Trial: 7963155
Drug: Prednisone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (0.5 mg/kg/day)
Trial: 23471817
Drug: Dosing cup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dosing cup
Trial: 18504547
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml white wine (approximately 25 g alcohol/day)
Trial: 1373337
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of high-osmolarity ionic contrast medium
Trial: 1373337
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of low-osmolarity non-ionic contrast medium
Trial: 1373337
Drug: Lower fixed
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower fixed dose of low-osmolarity non-ionic contrast medium
Trial: 31959346
Drug: Vemurafenib 960
RxNorm normalized name: Vemurafenib
DrugBank: Vemurafenib (DB08881)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vemurafenib 960 mg twice daily
Trial: 24297951
Drug: Intravenous calcium/magnesium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous calcium/magnesium before and after oxaliplatin
Trial: 22323092
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) administered intravenously, titrated according to a weight-adjusted dosing nomogram to a target aPTT of 1.5-2 times the upper limit of normal (approximately 50-70 s), median treatment duration of 42 hours.
Trial: 22323092
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) treatment with aPTT categorized as persistently below <50 s for recurrent ischemic events.
Trial: 22323092
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) treatment with aPTT categorized as persistently above >70 s for major hemorrhagic events.
Trial: 20196118
Drug: 24 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 24 weeks of peginterferon alfa‐2a (40KD) 180 microg/week plus ribavirin 800 mg/day